Alaa Cheikhelard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Alaa Cheikhelard has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Sabine Sarnacki
Department of Pediatric Surgery, Urology and Transplantation, Necker-Enfants Malades Hospital, APHP, Paris, France.
2 shared publications - Agnès Ferroni
Microbiology Laboratory
1 shared publication Christelle Guillet-Caruba
Assistance Publique-Hôpitaux de Paris, Laboratoire de Microbiologie, Hôpital Necker-Enfants Malades, Paris 75015, France
1 shared publicationClaire Nihoul-Fekete
G Department of Pediatric Surgery and Urology and Centre de Référence des Pathologies Gynécologiques Rares, AP-HP Hôpital Necker Enfants-malades, 149, rue de Sèvres, 75743, Paris Cedex 15, France and Université Paris Descartes, Paris, France
1 shared publicationDaniel Orbach
Pediatric and Adolescent Oncology Department, Institut Curie, Paris, France
1 shared publicationElisabeth Thibaud
B Department of Pediatric Endocrinology and Gynaecology, AP-HP Hôpital Necker Enfants-malades, 149, rue de Sèvres, 75743, Paris Cedex 15, France and Centre de Référence des Pathologies Gynécologiques Rares, AP-HP Hôpital Necker Enfants-malades, Paris, France
1 shared publication
Latest Publications
- 1 August 2015
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 50 (8) , 1329-1333
Urachal rhabdomyosarcoma in childhood: a rare entity with a poor outcome
- 1 August 2015
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 50 (8) , 1329-1333
Urachal rhabdomyosarcoma in childhood: a rare entity with a poor outcome
- 30 April 2011
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 69 (4) , 376-381
Bacteriologic epidemiology and empirical treatment of pediatric complicated appendicitis
- 30 April 2011
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 69 (4) , 376-381
Bacteriologic epidemiology and empirical treatment of pediatric complicated appendicitis
- 1 November 2009
- Published by Taylor & Francis in Expert Review of Endocrinology & Metabolism
- Vol. 4 (6) , 565-573
Complete androgen insensitivity syndrome: diagnosis and management
Complete androgen insensitivity syndrome (CAIS) is an X-linked genetic disorder affecting 46,XY individuals, characterized by the loss of function of the androgen receptor gene resulting in complete peripheral androgen resistance. Patients have a nonambiguous female phenotype with normal female external genitalia. Gonads are undescended testes (either intra-abdominal or inguinal), there is no uterus and the length of the vagina is usually very short. Gender identity is always female. This review focuses on the importance of accurate diagnosis of CAIS versus partial androgen insensitivity syndrome and other disorders of sex development by genotyping the androgen receptor, and raises issues of the optimal management of these patients. In the era of the Consensus Statement on Management of Intersex Disorders, we provide new insights into CAIS screening, surgical management of the gonads (balancing between hormonal production and malignancy risk) and of vaginal adequacy, and the ethics concerned with the disclosure to patients and their families.
- 1 November 2009
- Published by Taylor & Francis in Expert Review of Endocrinology & Metabolism
- Vol. 4 (6) , 565-573
Complete androgen insensitivity syndrome: diagnosis and management
Complete androgen insensitivity syndrome (CAIS) is an X-linked genetic disorder affecting 46,XY individuals, characterized by the loss of function of the androgen receptor gene resulting in complete peripheral androgen resistance. Patients have a nonambiguous female phenotype with normal female external genitalia. Gonads are undescended testes (either intra-abdominal or inguinal), there is no uterus and the length of the vagina is usually very short. Gender identity is always female. This review focuses on the importance of accurate diagnosis of CAIS versus partial androgen insensitivity syndrome and other disorders of sex development by genotyping the androgen receptor, and raises issues of the optimal management of these patients. In the era of the Consensus Statement on Management of Intersex Disorders, we provide new insights into CAIS screening, surgical management of the gonads (balancing between hormonal production and malignancy risk) and of vaginal adequacy, and the ethics concerned with the disclosure to patients and their families.